SCM
INBX icon

Sterling Capital Management’s Inhibrx INBX Stock Holding History

Sterling Capital Management’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.3K Sell
302
-226
-43% -$16.8K ﹤0.01% 2023
2025
Q4 		$41.7K Sell
528
-97
-16% -$6.61K ﹤0.01% 1863
2025
Q3 		$21.1K Buy
625
+380
+155% +$9.36K ﹤0.01% 2110
2025
Q2 		$3.5K Buy
245
+156
+175% +$2.02K ﹤0.01% 2709
2025
Q1 		$1.25K Sell
89
-69
-44% -$937 ﹤0.01% 2741
2024
Q4 		$2.43K Buy
158
+152
+2,533% +$2.31K ﹤0.01% 2728
2024
Q3 		$94 Buy
+6
New +$84 ﹤0.01% 3195

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Sterling Capital Management's INBX Position: Q1 2026 in Review

Sterling Capital Management reduced its Inhibrx (INBX) stake by 43% in Q1 2026, selling an estimated $16.8K and leaving 302 shares worth $20.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2023.

Sterling Capital Management first reported a position in INBX in Q3 2024 and has held it in 7 quarters since. The position peaked at $41.7K in Q4 2025. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • Sterling Capital Management held 302 shares of Inhibrx worth $20.3K as of Q1 2026.
  • Sterling Capital Management sold 226 Inhibrx shares in Q1 2026, an estimated $16.8K.
  • Inhibrx made up ﹤0.01% of Sterling Capital Management's portfolio in Q1 2026, its #2023 holding.
  • Sterling Capital Management first reported a position in Inhibrx in Q3 2024 and has held it in 7 quarters since.
  • Sterling Capital Management's Inhibrx position peaked at $41.7K in Q4 2025.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.